nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—HTR1A—G alpha (i) signalling events—POMC—multiple sclerosis	0.00159	0.00159	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CXCL10—multiple sclerosis	0.00159	0.00159	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CXCL13—multiple sclerosis	0.00158	0.00158	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCR1—multiple sclerosis	0.00158	0.00158	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00158	0.00158	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCR1—multiple sclerosis	0.00155	0.00155	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CXCL13—multiple sclerosis	0.00155	0.00155	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCR1—multiple sclerosis	0.00152	0.00152	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CXCL13—multiple sclerosis	0.00152	0.00152	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TAGAP—multiple sclerosis	0.00146	0.00146	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CXCL10—multiple sclerosis	0.00143	0.00143	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CCL5—multiple sclerosis	0.00143	0.00143	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TAGAP—multiple sclerosis	0.00142	0.00142	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CCL5—multiple sclerosis	0.0014	0.0014	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TAGAP—multiple sclerosis	0.00139	0.00139	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CCL5—multiple sclerosis	0.00136	0.00136	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CCL5—multiple sclerosis	0.00136	0.00136	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00132	0.00132	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00129	0.00129	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00129	0.00129	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CCR5—multiple sclerosis	0.00129	0.00129	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—S1PR1—multiple sclerosis	0.00127	0.00127	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00126	0.00126	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00126	0.00126	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CCR5—multiple sclerosis	0.00126	0.00126	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—S1PR1—multiple sclerosis	0.00125	0.00125	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GPC5—multiple sclerosis	0.00124	0.00124	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00123	0.00123	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CCL5—multiple sclerosis	0.00123	0.00123	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CCR5—multiple sclerosis	0.00123	0.00123	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CCR5—multiple sclerosis	0.00122	0.00122	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—S1PR1—multiple sclerosis	0.00122	0.00122	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GPC5—multiple sclerosis	0.00121	0.00121	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00121	0.00121	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.0012	0.0012	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.00119	0.00119	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GPC5—multiple sclerosis	0.00118	0.00118	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00117	0.00117	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00116	0.00116	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00115	0.00115	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00113	0.00113	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCL3—multiple sclerosis	0.00113	0.00113	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CCR2—multiple sclerosis	0.00113	0.00113	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCL3—multiple sclerosis	0.00113	0.00113	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SRM—multiple sclerosis	0.00113	0.00113	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CCR5—multiple sclerosis	0.00111	0.00111	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CXCR3—multiple sclerosis	0.00111	0.00111	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCL3—multiple sclerosis	0.00111	0.00111	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CCR2—multiple sclerosis	0.0011	0.0011	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL2RA—multiple sclerosis	0.0011	0.0011	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PTGER4—multiple sclerosis	0.00109	0.00109	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PTGER4—multiple sclerosis	0.00108	0.00108	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCL3—multiple sclerosis	0.00108	0.00108	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—RGS1—multiple sclerosis	0.00108	0.00108	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CCR2—multiple sclerosis	0.00108	0.00108	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PGR—multiple sclerosis	0.00107	0.00107	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PTGER4—multiple sclerosis	0.00107	0.00107	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RGS1—multiple sclerosis	0.00106	0.00106	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CXCR3—multiple sclerosis	0.00105	0.00105	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CXCR3—multiple sclerosis	0.00105	0.00105	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—POMC—multiple sclerosis	0.00104	0.00104	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PTGER4—multiple sclerosis	0.00104	0.00104	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CNR1—multiple sclerosis	0.00104	0.00104	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CD28—multiple sclerosis	0.00104	0.00104	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RGS1—multiple sclerosis	0.00104	0.00104	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CXCR3—multiple sclerosis	0.00103	0.00103	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GPR65—multiple sclerosis	0.00103	0.00103	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCR2—multiple sclerosis	0.00102	0.00102	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCR2—multiple sclerosis	0.00102	0.00102	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CNR1—multiple sclerosis	0.00102	0.00102	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CXCR3—multiple sclerosis	0.00101	0.00101	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—POMC—multiple sclerosis	0.001	0.001	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GPR65—multiple sclerosis	0.001	0.001	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCR2—multiple sclerosis	0.001	0.001	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CNR1—multiple sclerosis	0.000995	0.000995	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CCL2—multiple sclerosis	0.000983	0.000983	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—POMC—multiple sclerosis	0.000983	0.000983	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GPR65—multiple sclerosis	0.000981	0.000981	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCR2—multiple sclerosis	0.000979	0.000979	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CCL2—multiple sclerosis	0.000961	0.000961	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—POMC—multiple sclerosis	0.000961	0.000961	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000957	0.000957	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—POMC—multiple sclerosis	0.000956	0.000956	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CNR1—multiple sclerosis	0.000945	0.000945	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CNR1—multiple sclerosis	0.00094	0.00094	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CCL2—multiple sclerosis	0.00094	0.00094	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCR1—multiple sclerosis	0.000938	0.000938	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CXCL13—multiple sclerosis	0.000938	0.000938	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000937	0.000937	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CNR1—multiple sclerosis	0.000924	0.000924	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCR1—multiple sclerosis	0.000918	0.000918	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CXCL13—multiple sclerosis	0.000918	0.000918	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000916	0.000916	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CNR1—multiple sclerosis	0.000904	0.000904	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCR1—multiple sclerosis	0.000898	0.000898	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CXCL13—multiple sclerosis	0.000898	0.000898	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000896	0.000896	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—POMC—multiple sclerosis	0.000869	0.000869	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000851	0.000851	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CCL2—multiple sclerosis	0.00085	0.00085	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CXCL10—multiple sclerosis	0.000847	0.000847	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CXCL10—multiple sclerosis	0.000832	0.000832	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CXCL10—multiple sclerosis	0.000814	0.000814	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000806	0.000806	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	0.000793	0.000793	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	0.000793	0.000793	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CCL5—multiple sclerosis	0.000789	0.000789	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—TYK2—multiple sclerosis	0.000772	0.000772	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CCL5—multiple sclerosis	0.000771	0.000771	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CD86—multiple sclerosis	0.00074	0.00074	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCL5—multiple sclerosis	0.000732	0.000732	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCL5—multiple sclerosis	0.000729	0.000729	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000726	0.000726	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GPC5—multiple sclerosis	0.000725	0.000725	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCL5—multiple sclerosis	0.000716	0.000716	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000716	0.000716	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CCR5—multiple sclerosis	0.000711	0.000711	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—IL2—multiple sclerosis	0.000707	0.000707	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCL5—multiple sclerosis	0.0007	0.0007	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.0007	0.0007	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CCR5—multiple sclerosis	0.000695	0.000695	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000685	0.000685	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—SPP1—multiple sclerosis	0.000675	0.000675	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCL3—multiple sclerosis	0.000669	0.000669	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCR5—multiple sclerosis	0.00066	0.00066	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCR5—multiple sclerosis	0.000656	0.000656	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCL3—multiple sclerosis	0.000654	0.000654	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL2RA—multiple sclerosis	0.00065	0.00065	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL2RA—multiple sclerosis	0.000647	0.000647	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCR5—multiple sclerosis	0.000645	0.000645	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PTGER4—multiple sclerosis	0.000644	0.000644	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL2—multiple sclerosis	0.000642	0.000642	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL3—multiple sclerosis	0.00064	0.00064	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL2RA—multiple sclerosis	0.000636	0.000636	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PGR—multiple sclerosis	0.000634	0.000634	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCR5—multiple sclerosis	0.000631	0.000631	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PTGER4—multiple sclerosis	0.00063	0.00063	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL2RA—multiple sclerosis	0.000622	0.000622	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CXCR3—multiple sclerosis	0.000622	0.000622	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PGR—multiple sclerosis	0.00062	0.00062	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CD28—multiple sclerosis	0.000616	0.000616	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PTGER4—multiple sclerosis	0.000616	0.000616	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CXCR3—multiple sclerosis	0.000608	0.000608	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PGR—multiple sclerosis	0.000606	0.000606	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCR2—multiple sclerosis	0.000605	0.000605	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CD28—multiple sclerosis	0.000602	0.000602	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—RRM1—multiple sclerosis	0.000601	0.000601	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—APOE—multiple sclerosis	0.000597	0.000597	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CXCR3—multiple sclerosis	0.000595	0.000595	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCR2—multiple sclerosis	0.000591	0.000591	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CD28—multiple sclerosis	0.000589	0.000589	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCR2—multiple sclerosis	0.000578	0.000578	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—POMC—multiple sclerosis	0.000568	0.000568	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CNR1—multiple sclerosis	0.000558	0.000558	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—POMC—multiple sclerosis	0.000555	0.000555	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CNR1—multiple sclerosis	0.000546	0.000546	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—POMC—multiple sclerosis	0.000543	0.000543	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CD80—multiple sclerosis	0.00054	0.00054	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CNR1—multiple sclerosis	0.000534	0.000534	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—POMC—multiple sclerosis	0.000516	0.000516	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—POMC—multiple sclerosis	0.000513	0.000513	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCL2—multiple sclerosis	0.000504	0.000504	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—POMC—multiple sclerosis	0.000504	0.000504	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CXCL10—multiple sclerosis	0.000502	0.000502	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCL2—multiple sclerosis	0.000502	0.000502	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCL2—multiple sclerosis	0.000493	0.000493	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—POMC—multiple sclerosis	0.000493	0.000493	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CXCL10—multiple sclerosis	0.000491	0.000491	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—MAPK1—multiple sclerosis	0.000491	0.000491	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCL2—multiple sclerosis	0.000482	0.000482	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CXCL10—multiple sclerosis	0.000481	0.000481	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—TYK2—multiple sclerosis	0.000458	0.000458	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TYK2—multiple sclerosis	0.000456	0.000456	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—TYK2—multiple sclerosis	0.000448	0.000448	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CD86—multiple sclerosis	0.000439	0.000439	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—TYK2—multiple sclerosis	0.000438	0.000438	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCL5—multiple sclerosis	0.000432	0.000432	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CD86—multiple sclerosis	0.00043	0.00043	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCL5—multiple sclerosis	0.000423	0.000423	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CD86—multiple sclerosis	0.00042	0.00042	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—IL2—multiple sclerosis	0.00042	0.00042	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL5—multiple sclerosis	0.000414	0.000414	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—IL2—multiple sclerosis	0.000411	0.000411	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—IL2—multiple sclerosis	0.000401	0.000401	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—SPP1—multiple sclerosis	0.000401	0.000401	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—SPP1—multiple sclerosis	0.000392	0.000392	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCR5—multiple sclerosis	0.00039	0.00039	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL2RA—multiple sclerosis	0.000384	0.000384	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	0.000383	0.000383	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCR5—multiple sclerosis	0.000381	0.000381	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL2—multiple sclerosis	0.000381	0.000381	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL2—multiple sclerosis	0.000379	0.000379	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL6—multiple sclerosis	0.000377	0.000377	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL2RA—multiple sclerosis	0.000376	0.000376	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL2—multiple sclerosis	0.000373	0.000373	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	0.000373	0.000373	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	0.000367	0.000367	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	0.000365	0.000365	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MMP9—multiple sclerosis	0.000359	0.000359	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—APOE—multiple sclerosis	0.000354	0.000354	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—APOE—multiple sclerosis	0.000347	0.000347	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—BCHE—multiple sclerosis	0.000345	0.000345	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—APOE—multiple sclerosis	0.000339	0.000339	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CD80—multiple sclerosis	0.000321	0.000321	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—STAT3—multiple sclerosis	0.000319	0.000319	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CD80—multiple sclerosis	0.000314	0.000314	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CD80—multiple sclerosis	0.000307	0.000307	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—POMC—multiple sclerosis	0.000305	0.000305	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	0.000298	0.000298	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—POMC—multiple sclerosis	0.000298	0.000298	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MYC—multiple sclerosis	0.000297	0.000297	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TGFB1—multiple sclerosis	0.000296	0.000296	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000292	0.000292	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	0.000291	0.000291	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—POMC—multiple sclerosis	0.000291	0.000291	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MAPK1—multiple sclerosis	0.00029	0.00029	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	0.000285	0.000285	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	0.000285	0.000285	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	0.000279	0.000279	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	0.000271	0.000271	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	0.000265	0.000265	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	0.000259	0.000259	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL2—multiple sclerosis	0.000225	0.000225	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	0.000224	0.000224	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL6—multiple sclerosis	0.000223	0.000223	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL2—multiple sclerosis	0.00022	0.00022	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	0.000219	0.000219	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL2—multiple sclerosis	0.000215	0.000215	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	0.000214	0.000214	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	0.000213	0.000213	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	0.000208	0.000208	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—APOE—multiple sclerosis	0.000208	0.000208	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	0.000204	0.000204	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	0.000189	0.000189	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	0.000185	0.000185	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	0.000181	0.000181	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—POMC—multiple sclerosis	0.000178	0.000178	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MYC—multiple sclerosis	0.000176	0.000176	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	0.000176	0.000176	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	0.000172	0.000172	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MYC—multiple sclerosis	0.000172	0.000172	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	0.000172	0.000172	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	0.000168	0.000168	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MYC—multiple sclerosis	0.000168	0.000168	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	0.000168	0.000168	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	0.000165	0.000165	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ALB—multiple sclerosis	0.000163	0.000163	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL6—multiple sclerosis	0.000132	0.000132	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL6—multiple sclerosis	0.000129	0.000129	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL6—multiple sclerosis	0.000127	0.000127	CbGpPWpGaD
